NO882635L - Fremgangsmaate for fremstilling av proteiner i aktive former. - Google Patents

Fremgangsmaate for fremstilling av proteiner i aktive former.

Info

Publication number
NO882635L
NO882635L NO882635A NO882635A NO882635L NO 882635 L NO882635 L NO 882635L NO 882635 A NO882635 A NO 882635A NO 882635 A NO882635 A NO 882635A NO 882635 L NO882635 L NO 882635L
Authority
NO
Norway
Prior art keywords
procedure
active forms
producing proteins
host cells
proteins
Prior art date
Application number
NO882635A
Other languages
English (en)
Norwegian (no)
Other versions
NO882635D0 (no
Inventor
Joseph John Patroni
Malcolm Roy Brandon
Original Assignee
Bunge Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bunge Australia filed Critical Bunge Australia
Publication of NO882635D0 publication Critical patent/NO882635D0/no
Publication of NO882635L publication Critical patent/NO882635L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO882635A 1987-06-15 1988-06-15 Fremgangsmaate for fremstilling av proteiner i aktive former. NO882635L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI247287 1987-06-15

Publications (2)

Publication Number Publication Date
NO882635D0 NO882635D0 (no) 1988-06-15
NO882635L true NO882635L (no) 1988-12-19

Family

ID=3772234

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882635A NO882635L (no) 1987-06-15 1988-06-15 Fremgangsmaate for fremstilling av proteiner i aktive former.

Country Status (14)

Country Link
US (1) US4992531A (de)
JP (1) JPS6447389A (de)
KR (1) KR0126767B1 (de)
CN (1) CN1032425C (de)
AT (1) ATE114156T1 (de)
AU (1) AU609824B2 (de)
CA (1) CA1305284C (de)
DE (1) DE3852116T2 (de)
DK (1) DK322188A (de)
ES (1) ES2065911T3 (de)
IE (1) IE66334B1 (de)
NO (1) NO882635L (de)
NZ (1) NZ225032A (de)
ZA (1) ZA884212B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (de) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Herstellung von Proteinen in aktiver Form
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
JPH0774232B2 (ja) * 1992-08-31 1995-08-09 農林水産省食品総合研究所長 界面活性剤を用いたタンパク質の新規な精製法
JP3279362B2 (ja) * 1992-10-05 2002-04-30 井上 聰一 糖尿病判定方法及び糖尿病判定装置
JP3319812B2 (ja) * 1993-04-05 2002-09-03 井上 聰一 リウマチ判定方法及びリウマチ判定装置
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
CA2338665C (en) 1998-08-06 2011-01-18 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
CN1318443C (zh) * 2000-05-16 2007-05-30 博尔德生物技术公司 含游离半胱氨酸残基的蛋白重折叠的方法
CA2497560A1 (en) 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
EP1558748A4 (de) * 2002-11-01 2008-10-22 Promega Corp Zellysezusammensetzungen, verwendungsverfahren, vorrichtung und kit
DE10309691B4 (de) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
US20040180445A1 (en) * 2003-03-12 2004-09-16 Domanico Michael J. Methods and compositions for purification of nucleic acid from a host cell
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8188224B2 (en) 2005-04-11 2012-05-29 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
WO2008051178A2 (en) 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
US7811800B2 (en) 2005-04-11 2010-10-12 Savient Pharmaceuticals, Inc. Variant form of urate oxidase and use thereof
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
JP2008545665A (ja) * 2005-05-23 2008-12-18 ユニベルシテ ドゥ ジュネーブ 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用
EP1885875B1 (de) 2005-05-31 2019-05-22 Promega Corporation Luminogene und fluorogene verbindungen und verfahren für den nachweis von molekülen oder leiden
EP2102355B1 (de) 2006-12-14 2016-03-02 Bolder Biotechnology, Inc. Proteine und peptide mit langer wirkung sowie verfahren zu ihrer herstellung und verwendung
JP5597200B2 (ja) * 2008-08-18 2014-10-01 プロメガ コーポレイション ルミネッセンスを生じる化合物およびチトクロムｐ４５０３ａ酵素を検出するための方法
GB0901434D0 (en) 2009-01-29 2009-03-11 Univ Strathclyde Ballast water treatment system
EP4635567A3 (de) 2009-06-25 2025-12-03 Horizon Therapeutics USA, Inc. Verfahren und kits zur prävention des infusionsreaktionsrisikos und antikörpervermittelter reaktionsverlust durch überwachung von serumharnsäure während der pegylierten harnasetherapie
WO2011146595A2 (en) * 2010-05-21 2011-11-24 Siemens Healthcare Diagnostics Inc. Zwitterionic reagents
CN102965317A (zh) * 2012-11-27 2013-03-13 江南大学 一种产牛磺酸菌株的筛选方法及用该菌株发酵法生产牛磺酸
EP3099683B1 (de) 2014-01-29 2020-08-05 Promega Corporation Chinonmaskierte sonden als markierungsreagenzien für zellaufnahmemessungen
EP3172332B1 (de) * 2014-07-22 2020-10-14 Bio-rad Laboratories, Inc. Puffer zur verwendung mit polymerasen
CN110234340A (zh) 2016-11-11 2019-09-13 好利恩风湿病制药有限责任公司 泼尼松和尿酸酶分子的组合疗法及其用途
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
US12121566B2 (en) 2019-01-30 2024-10-22 Horizon Therapeutics Usa, Inc. Methods for treating gout
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms

Also Published As

Publication number Publication date
IE66334B1 (en) 1995-12-27
ZA884212B (en) 1989-03-29
CN88103725A (zh) 1988-12-28
CA1305284C (en) 1992-07-14
AU1763288A (en) 1988-12-15
ATE114156T1 (de) 1994-12-15
DE3852116D1 (de) 1994-12-22
NZ225032A (en) 1991-02-26
ES2065911T3 (es) 1995-03-01
NO882635D0 (no) 1988-06-15
JPS6447389A (en) 1989-02-21
IE881815L (en) 1988-12-15
AU609824B2 (en) 1991-05-09
CN1032425C (zh) 1996-07-31
DK322188D0 (da) 1988-06-14
DE3852116T2 (de) 1995-03-30
US4992531A (en) 1991-02-12
KR900000380A (ko) 1990-01-30
DK322188A (da) 1988-12-17
KR0126767B1 (ko) 1997-12-29

Similar Documents

Publication Publication Date Title
NO882635L (no) Fremgangsmaate for fremstilling av proteiner i aktive former.
MY101204A (en) Solubilization of protein aggregates
BR9506835A (pt) Acido micofenólico substituído em 6 e derivados
DK512686D0 (da) Thrombinpraeparater, deres fremstilling og anvendelse
SE8903777L (sv) Liposome/doxorubicin, komposition och foerfarande
DK0429570T3 (da) Osteoinducerende præparater
NO901852L (no) Fremgangsmaate for fremstilling av liposomer.
ATE114319T1 (de) Produktion von proteinen in aktiven formen.
ATE132040T1 (de) Verwendung von phospholipiden zur herstellung eines topischen arzneimittels zur beinflussung des serumcholesterinspiegels
HU9202435D0 (en) Blood factors produced by a recombinant process, method for expressing said bloode factors and recombinant vaccina viruses utilized in said method
DK7191A (da) Topisk salve
MY103362A (en) Production of proteins in active forms
ATE168115T1 (de) In lösung bringen von proteinen in aktiver form
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
DE69524388D1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
ATE165826T1 (de) 4-aminoderivate von 5-substituierten mycophenolsäuren
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
MY103305A (en) Productions of proteins in active forms